AC Followed by Pembrolizumab Regimen

Preferred Label : AC Followed by Pembrolizumab Regimen;

NCIt synonyms : Cyclophosphamide-Doxorubicin-Pembrolizumab Regimen; Adriamycin/Cytoxan Followed by Keytruda Regimen; AC/Pembrolizumab Regimen; Doxorubicin/Cyclophosphamide Followed by Pembrolizumab Regimen; AC-Pembrolizumab Regimen; Cyclophosphamide/Doxorubicin/Pembrolizumab; AC Plus Pembrolizumab Regimen; Cyclophosphamide/Doxorubicin/Pembrolizumab Regimen; Cyclophosphamide-Doxorubicin-Pembrolizumab;

NCIt definition : A regimen consisting of cyclophosphamide and doxorubicin followed by pembrolizumab, used as a neoadjuvant or adjuvant treatment for HER-2 (EGFR2; ErbB2)-negative and hormone receptor-negative breast cancer.;

NCI Metathesaurus CUI : CL1664645;

Details

Origin ID

C181771;

UMLS CUI

C5557256;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Doxorubicin [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients